TD-1439

DRUG2 trials

Sponsors

Theravance Biopharma

Conditions

Healthy Adults, Elderly SubjectsHealthy Subjects

Phase 1

Single Ascending Dose Study of TD-1439 in Healthy Subjects

CompletedNCT02903095

Theravance BiopharmaHealthy Subjects

Start: 2016-09-30End: 2017-02-28Updated: 2021-01-19

Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects

CompletedNCT02954263

Theravance BiopharmaHealthy Adults, Elderly Subjects

Start: 2016-11-30End: 2017-04-30Updated: 2021-01-20